PMEL and melanoma: Melanoma antigen gp100-specific CD8 T cell populations, as represented by H-2Db-restricted gp100-tetramer+ population, were significantly enriched in tumors with B10G5, but not with anti-PDL1, single-agent therapy (Fig. 3g, h).